FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064272 [Registered on: 18/03/2024] Trial Registered Prospectively
Last Modified On: 11/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Other 
Public Title of Study   To study the effect of tablet Mifepristone (200 mg) in induction of labour in term pregnancy in a tertiary care hospital at chengalpatu district. 
Scientific Title of Study   To determine the effect of tablet Mifepristone (200mg) in induction of labour at term in a tertiary care centre at chengalpattu district a prospective study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Thiripurasundari 
Designation  Assistant professor  
Affiliation  Karpaga vinayaga institute of medical sciences and research centre  
Address  No186thirukazhukundram mainroad alapakkam chengalpatu
No186thirukazhukundram mainroad alapakkam chengalpatu
Kancheepuram
TAMIL NADU
603003
India 
Phone  9488237145  
Fax    
Email  thiripurasundariramesh@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Thiripurasundari 
Designation  Assistant professor  
Affiliation  Karpaga vinayaga institute of medical sciences and research centre  
Address  No186thirukazhukundram mainroad alapakkam chengalpatu
No186thirukazhukundram mainroad alapakkam chengalpatu

TAMIL NADU
603003
India 
Phone  9488237145  
Fax    
Email  thiripurasundariramesh@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Thiripurasundari 
Designation  Assistant professor  
Affiliation  Karpaga vinayaga institute of medical sciences and research centre  
Address  No186thirukazhukundram mainroad alapakkam chengalpatu
No186thirukazhukundram mainroad alapakkam chengalpatu

TAMIL NADU
603003
India 
Phone  9488237145  
Fax    
Email  thiripurasundariramesh@yahoo.com  
 
Source of Monetary or Material Support  
Karpaga Vinayaga Institute Of Medical Sciences and Research Centre  
 
Primary Sponsor  
Name  Thiripurasundari  
Address  No 186 Thirukazhukundram main road alapakkam chengalpatu  
Type of Sponsor  Other [Self funding ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrsThiripurasundari  Karpaga Vinayaga Institute Of Medical Sciences and Research Centre   No 35, department of obstetrics and gynaecology karpaga Vinayaga Institute Of Medical Sciences and Research Centre chinna kolambakkam Madurantakam chengalpatu
Kancheepuram
TAMIL NADU 
9488237145

thiripurasundariramesh@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Karpaga Vinayaga Institute Of Medical Sciences and Research Centre   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Term pregnant women admitted in labour ward for induction of labour  
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Tablet Mifepristone   Soften the cervix and improves the modified bishops score .dosage is 200 mg tablet once orally. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Term pregnant women admitted in labour ward for induction of labour in karpaga vinayaga institute of medical sciences and research centre.without any risk factors  
 
ExclusionCriteria 
Details  Pregnant women with risk factors like preterm labour, diabetes, hypertension, antepartum haemorrhage,CPD,fever,anyother infection, fetal distress,malpresentation,heart disease,liver disease and any other medical illness. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in modified bishops scoring.increase
in rate of normal vaginal delivery  
48 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Normal vaginal delivery   24 to 48 hours 
 
Target Sample Size   Total Sample Size="185"
Sample Size from India="185" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  25/03/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="6" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Term pregnant women admitted in labour ward for induction of labour with out any other medical illness and risk factors are given tablet Mifepristone 200 mg tablet orally.modified bishops score assesed before giving the tablet and at 24 hours and 48 hours . 
Close